MicroRNA-21 and MicroRNA-208a as Biomarkers of Myocardial Remodeling Post-Infarction
Advanced Journal of Biomedicine & Medicine · 30.06.2026 · 14 (2) · 82-97
DOI: 10.18081/ajbm.2026.2.82 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Journal of Biomedicine & Medicine, online erschienen am 30.06.2026. Verfasst von Alessandro Conti und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Myocardial remodeling following acute myocardial infarction (AMI) is a critical determinant of long-term cardiac function and progression to heart failure. Conventional biomarkers provide limited insight into the molecular mechanisms underlying this process. MicroRNAs (miRNAs), particularly microRNA-21 (miR-21) and microRNA-208a (miR-208a), have emerged as potential regulators of fibrosis and myocardial injury, respectively, and may serve as novel biomarkers of post-infarction remodeling.
Methods
This prospective observational study was conducted at two tertiary centers in Italy and included 60 patients with confirmed AMI and 20 healthy controls. Plasma levels of miR-21 and miR-208a were measured using quantitative real-time PCR at admission (T0), 72 hours (T1), and 3 months (T2). Echocardiographic assessment of left ventricular function and volumes was performed at baseline and 3-month follow-up. Adverse remodeling was defined as a ≥20% increase in left ventricular end-diastolic volume. Statistical analysis included correlation studies, receiver operating characteristic (ROC) curve analysis, and multivariate logistic regression.
Results
Both miR-21 and miR-208a levels were significantly elevated in AMI patients compared to controls (p < 0.001). MiR-21 peaked at 72 hours (5.2 ± 1.6-fold increase), while miR-208a showed highest levels at admission (4.5 ± 1.5-fold). Adverse remodeling occurred in 36.7% of patients. MiR-21 levels were significantly higher in patients with remodeling (5.9 ± 1.4 vs 3.7 ± 1.1; p < 0.001) and showed strong correlations with left ventricular ejection fraction (r = −0.62) and LVEDV (r = 0.58). MiR-208a correlated with troponin levels (r = 0.65, p < 0.001) and remodeling status (p = 0.002). ROC analysis demonstrated good predictive performance for miR-21 (AUC = 0.87) and miR-208a (AUC = 0.82), with improved accuracy when combined (AUC = 0.91). Multivariate analysis identified miR-21 and miR-208a as independent predictors of remodeling.
Conclusion
Circulating miR-21 and miR-208a are promising non-invasive biomarkers for assessing myocardial remodeling following AMI. MiR-21 is strongly associated with fibrotic remodeling, whereas miR-208a reflects myocardial injury severity. Their combined use enhances predictive accuracy and may support early risk stratification and personalized management of patients with post-infarction conditions. Keywords: MicroRNA-21; MicroRNA-208a; Myocardial Infarction; Cardiac Remodeling; Biomarkers; Left Ventricular Dysfunction; Fibrosis.
Zitieren
APA
Conti, A., & Rinaldi, F. (2026). MicroRNA-21 and MicroRNA-208a as Biomarkers of Myocardial Remodeling Post-Infarction. Advanced Journal of Biomedicine & Medicine, 14(2), 82-97. https://doi.org/10.18081/ajbm.2026.2.82
Vancouver
Conti A, Rinaldi F. MicroRNA-21 and MicroRNA-208a as Biomarkers of Myocardial Remodeling Post-Infarction. Advanced Journal of Biomedicine & Medicine. 2026;14(2):82-97. doi:10.18081/ajbm.2026.2.82
BibTeX
@article{Conti2026,
author = {Conti, Alessandro and Rinaldi, Francesca},
title = {MicroRNA-21 and MicroRNA-208a as Biomarkers of Myocardial Remodeling Post-Infarction},
journal = {Advanced Journal of Biomedicine & Medicine},
year = {2026},
volume = {14},
number = {2},
pages = {82--97},
doi = {10.18081/ajbm.2026.2.82}
}
EUVIMED